InnovAge Holding Corp (INNV)

NASD · Healthcare · Medical Care Facilities · USA

InnovAge Holding Corp is a small cap company (market value between $300 million and $2 billion) in the Medical Care Facilities industry.

InnovAge is a healthcare delivery platform providing all-inclusive, capitated care to dual-eligible seniors through PACE programs. The company delivers comprehensive medical and support services including in-home care, primary care, mental health services, meals, and transportation via direct contracts with Medicare and Medicaid. InnovAge operates PACE centers across multiple U.S. states.

From its FY2026 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the InnovAge Holding Corp stock.

Our verdict on INNV

Overvalued: intrinsic value $2.03 per share, market price $9.42, margin of safety -363.1% (as of 2026-11-17).

Discounting its cash flows at 9.5% (average of 3 methods) values the shares at $2.03; the price of $9.42 is 363% above that value, and 75% of that value comes from beyond year five.

ETFs with the most weight in INNV

17 more funds hold it; the full list is part of the paid plan.

More on INNV

Browse

Peers in Medical Care Facilities

All 48 Medical Care Facilities stocks

Cheaper than INNV in Medical Care Facilities

25 more in this industry show a wider margin of safety.

Is INNV undervalued or overvalued?

INNV is overvalued (as of the 2026-11-17 close). Discounting its cash flows at 9.5% (average of 3 methods) values the shares at $2.03; the price of $9.42 is 363% above that value, and 75% of that value comes from beyond year five.

What is the intrinsic value of INNV?

$2.03 per share (as of the 2026-11-17 close), against a market price of $9.42. That is a margin of safety of -363.1%. The value is the average of the 3 valuation methods that apply to this company, recomputed every night after the US close.